Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
Post-LT biopsies show histologic features of HCV following SVR
Results of a retrospective analysis showed histologic changes associated with active hepatitis C in patients who had achieved sustained virologic response following liver transplantation for chronic HCV.
HCV infections in US nearly triple in 5 years
The number of hepatitis C virus infections reported yearly in the United States has tripled since 2010, reaching a 15-year high, according to the CDC.
Log in or Sign up for Free to view tailored content for your specialty!
Multidisciplinary hepatitis C treatment program yields results
A hepatitis C treatment program at an urban safety-net hospital that utilized a public health social worker, general internists trained in hepatitis C treatment, pharmacists, and pharmacy technicians led to nearly one out of every four referrals receiving treatment, according to research recently published in Annals of Family Medicine.
Rise of HCV among reproductive-age women suggests need for screening
A recent substantial increase in hepatitis C virus infection among reproduction-aged women in the United States highlights a need for routine HCV screening during pregnancy, according to recent data published in Annals Internal Medicine.
CDC: Blacks living longer, but still lag behind whites
Although the death rate for blacks declined 25% from 1999 to 2015, there are still disparities between blacks and whites, according to a recent CDC Vital Signs report. In addition, blacks are living longer, but their life expectancy is still 4 years less than that of whites.
Sofosbuvir-velpatasvir safe, effective for patients with HIV/HCV coinfection
Treatment with sofosbuvir and velpatasvir produced a safe, sustained virologic response in patients with HIV who were coinfected with hepatitis C virus, according to findings from a phase 3 study.
Harvoni yields 100% SVR12 in HBV/HCV coinfected cohort
AMSTERDAM — All 111 of a cohort of patients in Taiwan coinfected with both hepatitis B and hepatitis C who were treated with Harvoni reached sustained virologic response at 12 weeks, according to data presented at the International Liver Congress.
Western, Southern US states face the highest prevalence of HCV infection
A state-level evaluation of the burden of hepatitis C virus infection revealed that states in the Western and Southern United States are most impacted by the disease.
SVR achieved after transplantation with HCV-infected kidneys
In a recent pilot trial, patients who were previously hepatitis C-negative had detectable HCV RNA after transplantation with HCV-infected kidneys. All patients in the trial achieved sustained virologic response with Zepatier.
Experts: We must increase access to HCV treatment for substance users
In a recent editorial, experts discussed the necessity to optimize control and treatment of hepatitis C among patients with substance abuse disorders, to further the goal of HCV elimination.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read